Controlling the increased epidermal proliferation characteristic of psoriasis is a goal of treatment. Systemic treatment with antimetabolites is limited by sometimes severe side-effects; side-effects from topical administration of antimetabolites have been minimal and have important therapeutic applications. We are testing topical 5FU in the treatment of psoriasis.
Showing the most recent 10 out of 461 publications